Johnson & Johnson (JNJ) EBITDA (2009 - 2026)
Johnson & Johnson (JNJ) recorded EBITDA of $9.1 billion in Q2 2026, up 5.9% from $8.59 billion a year earlier and up 8.7% from the prior quarter.
Powered by 
Analysis
Johnson & Johnson (JNJ) EBITDA (2009 - 2026) Analysis & Trends
On a TTM basis, Johnson & Johnson's EBITDA came in at $33.79 billion as of Jun 28, 2026, up 16.8% year-over-year; for FY2025, it was $32.87 billion, up 15.9% from FY2024.
- Annual EBITDA has a four-year compound annual growth rate of 5.1% (FY2021 to FY2025).
- Across earlier years, EBITDA came in at $28.35 billion in FY2024 (-2.2%), $29.01 billion in FY2023 (+4.7%), $27.71 billion in FY2022 and $26.9 billion in FY2021.
- The Q2 2026 figure is the highest quarterly EBITDA in data going back to Q4 2011.
- On a year-over-year basis, EBITDA has increased for six consecutive quarters, with growth averaging 8.0% over the last eight quarters.
- Peak year-over-year performance for EBITDA in the last five years was growth of 36.8% in Q4 2025, against a decline of 26.5% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $8.37 billion (Q1 2026), $7.52 billion (Q4 2025) and $8.81 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Bristol Myers Squibb | 130.49 Bn | 81.76 Bn | 9.25 Bn | 954.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 9.10 Bn |
| Mar 29, 2026 | 8.37 Bn |
| Dec 28, 2025 | 7.52 Bn |
| Sep 28, 2025 | 8.81 Bn |
| Jun 29, 2025 | 8.59 Bn |
| Mar 30, 2025 | 7.95 Bn |
| Dec 29, 2024 | 5.50 Bn |
| Sep 29, 2024 | 6.88 Bn |
| Jun 30, 2024 | 8.25 Bn |
| Mar 31, 2024 | 7.72 Bn |
| Dec 31, 2023 | 6.09 Bn |
| Oct 1, 2023 | 7.57 Bn |
| Jul 2, 2023 | 7.75 Bn |
| Apr 2, 2023 | 7.60 Bn |
| Jan 1, 2023 | 8.29 Bn |
| Apr 3, 2022 | 6.12 Bn |
| Oct 3, 2021 | 8.42 Bn |
| Jul 4, 2021 | 8.04 Bn |
| Apr 4, 2021 | 8.49 Bn |
| Jan 3, 2021 | 10.08 Bn |
API Access
Johnson & Johnson EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=JNJ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();